Luke Strnad, MD

Luke Strnad, MD

Luke Strnad, MD
Associate Professor of Medicine, Division of Infectious Diseases, OHSU
Assistant Professor of Epidemiology Programs, OHSU-PSU School of Public Health 
Associate Program Director, OHSU Infectious Disease Fellowship


B.A. - Seattle Pacific University, 2005
M.D. - Loma Linda University School of Medicine, 2010


Intern and Resident, Internal Medicine, Beth Israel Deaconess Department of Medicine, 2013 
Chief Resident, Internal Medicine, Beth Israel Deaconess Department of Medicine, 2014


Infectious Diseases, University of California - San Francisco, 2016

Board certification

American Board of Internal Medicine Board Certification, 2013
American Board of Internal Medicine, Infectious Disease Board Certification, 2016

Clinical interests

  • Mycobacterial infections (Tuberculous Mycobacteria and Nontuberculous Mycobacteria)
  • Staphylococcus aureus infections
  • Bacterial endocarditis
  • Human Immunodeficiency Virus (HIV) infections and complications
  • Addiction medicine

Research interests

  • Non-tuberculous mycobacterial infections
  • Staphylococcus aureus bacteremia
  • Medical education interventions in the graduate setting
  • Infections in populations with active substance use


Dr. Strnad completed medical school at Loma Linda University School of Medicine before switching coasts to Boston for his internal medicine residency and chief residency at the Beth Israel Deaconess Department of Medicine (BIDMC) where he became board certified in internal medicine. He traveled back west for his infectious disease fellowship  at the University of California San Francisco (UCSF) where he was a chief fellow. He joined the OHSU infectious diseases faculty in 2016 where he is board certified in infectious diseases. He also has a secondary faculty appointment in the OHSU/PSU School of Public Health in Epidemiology programs.

Dr. Strnad is on the clinician educator faculty pathway within the School of Medicine and spends time teaching in the medical school, internal medicine residency, and infectious disease fellowship programs as well as the affiliated OHSU/PSU School of Public Health (SPH). He was recognized for these efforts with a junior faculty teaching award from the internal medicine residency in 2017. Dr. Strnad is the Associate Program Director for the Infectious Diseases Fellowship as well as the director of the infectious diseases fellowship's HIV curriculum, the director of the infectious disease fellowship’s non-tuberculous mycobacterial (NTM) elective and it’s non-ACGME Chronic Chest & Mycobacterial Infection Fellowship, a committee member of the IDSA’s Community of Practice Mentoring Workgroup, and a member, advisory group member, and current advisory group Chair of OHSU's Educators Collaborative. In the SPH he serves as core project review faculty for the Epidemiology programs Integrative Projects.

Dr. Strnad has specific clinical and academic focuses in mycobacterial infections, Staphylococcus aureus infections, and infections in populations with active substance use. While in his infectious diseases fellowship at UCSF, his clinical, academic, and public health work was primarily focused on tuberculosis.  He currently does clinical TB work in conjunction with the Oregon State TB Program and non-tuberculous mycobacterial (NTM) clinical, educational, and academic work at OHSU in collaboration with Dr. Kevin Winthrop, Dr. Cara Varley and the OHSU-PSU School of Public Health Center for Infectious Diseases where he is a Co-PI on numerous studies regarding NTM disease. While in fellowship Dr. Strnad also initiated an ongoing quality improvement (QI) project for Staph aureus bacteremia at UCSF, and now oversees a clinical cohort and QI projects regarding Staph aureus bacteremia. He is a site PI for an NIH-funded randomized control trial on the treatment of Staph aureus bacteremia and is currently a member of the IDSA/ESCMID Clinical Practice Guidelines for Staphylococcus Aureus Bacteremia. Dr. Strnad is involved collaborative work with OHSU's addiction medicine program (IMPACT) designing and evaluating different models of care for patients with active substance use disorders and concomitant bacterial infections as well as a founding and active member of the leadership team for OHSU’s Multidisciplinary Endocarditis (MEND) Program. In recognition of his academic mentoring of trainees, he was awarded the Faculty Contributions to Scholarship Award from the internal medicine residency in 2020.

In his spare time Dr. Strnad enjoys taking walks through the city, exploring the Portland food scene and going hiking and camping in the beautiful outdoors of the Pacific Northwest. He also likes to run, play board games and is an avid ice hockey fan.

Selected publications

  1. Sikka M, Gore S, Vega T, Strnad L, Gregg J, Englander H. “OPTIONS‑DC”, a feasible discharge planning conference to expand infection treatment options for people with substance use disorder. BMC Infect Dis. 2021. 21:772
  2. Bhamidipati CM, Strnad L, Riquelme PA. Time to revise surgical infectious endocarditis paradigms: Multidisciplinary and comprehensive care. Ann Thorac Surg. 2021 Mar 9;S0003-4975(21)00482-3.
  3. Trinh T, Strnad L,Damon L, Dzundza JH, Graff LR, Griffith LM, Hilts-Horeczko A, Olin R, Shenoy S, DeVoe C, Wang L, Rodriguez-Monguio R, Gu TM, Hampton SR, Macapinlac BA, Yang K, Doernberg SB. Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis. Infect Control Hosp Epidemiol. 2021 Jan 25;1-8.
  4. Capizzi J, Leahy J, Wheelock H, Garcia J, Strnad L, Sikka M, Englander H, Thomas A, Korthuis PT, Menza TW. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018. PLoS One. 2020 Nov 9;15(11):e0242165.
  5. Strnad L, Winthrop K. Book Chapter: Mycobacterium Avium Complex. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: 9th Edition. September 2019.
  6. Nathavitharana RR, Strnad L, Lederer PA, Shah M, Hurtado RM. Top Questions in the Diagnosis and Treatment of Pulmonary M. abscessus Disease. Open Forum Infect Dis. 2019 May 14;6(7):ofz221.
  7. Tapper EB, Strnad L, Shmerling R. Reducing the Burden of False-Positive Tests: It Is Time to Optimize Diagnostic Testing for Undifferentiated Conditions. Mayo Clin Proc. 2019 Jul;94(7):1143-1146.
  8. Shete PB, Farr K, Strnad L, Gray CM, Cattamanchi A. Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2019 Mar 19;19(1):268.
  9. Liu C, Strnad L, Beekman SE, Polgreen PM, Chambers HF. Clinical Practice Variation Among Adult Infectious Diseases Physicians in the Management of Staphylococcus aureus Bacteremia. CID. 2019 Jan 2. doi: 10.1093/cid/ciy1144
  10. Strnad, L and Winthrop, KL. Treatment of Mycobacterium abscessus Complex. Semin Respir Crit Care Med. 2018 Jun;39(3):362-376

Selected National Talks

  1. Invited Lecture: Incorporating teaching and role modeling around social determinants of health. Location: Philadelphia, ID Week –Oct 21, 2020.
  2. Invited Lecture: Meet the Professor Session: Clinical Teaching for the ID Provider. Co-presenter: Wendy Stead, MD. Location: San Francisco, ID Week –Oct 6, 2018.
  3. Research Abstract: Tuberculosis Screening in People Living with HIV Based on Plasma Cytokine and Chemokine Levels. Location: San Francisco, American Thoracic Society -May 2016.